Tech Company Financing Transactions
Annexon Biosciences Funding Round
On 7/30/2026, Annexon Biosciences landed $200 million in financing from Oxford Finance.
Transaction Overview
Company Name
Announced On
7/30/2026
Transaction Type
Debt
Amount
$200,000,000
Round
Undisclosed
Investors
Oxford Finance (Kirk Andrews)
Proceeds Purpose
This strategic facility enhances our financial and operational capabilities as we prepare for the potential global commercialization of vonaprument and tanruprubart, which combined have the potential to reach millions of patients worldwide
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
180 Kimball Way 2nd Floor 200
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Annexon is a California-based healthcare company engaged in the R&D of novel disease-modifying drugs for neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Love
Chief Financial Officer
Jennifer Lew
Chief Medical Officer
Sanjay Keswani
Chief Scientific Officer
Ted Yednock
Browse more venture capital transactions:
Prev: 7/30/2026: Extropic venture capital transaction
Next: 7/30/2026: Bon Credit venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs